Chemoinformaics analysis of 9,12,13-TRIHYDROXY-OCTADEC-TRANS-10-ENOIC-ACID
| Molecular Weight | 252.398 | nRot | 12 |
| Heavy Atom Molecular Weight | 224.174 | nRig | 3 |
| Exact Molecular Weight | 252.209 | nRing | 0 |
| Solubility: LogS | -4.498 | nHRing | 0 |
| Solubility: LogP | 5.741 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 46.9942 |
| nHD | 1 | BPOL | 28.9578 |
| QED | 0.387 |
| Synth | 2.358 |
| Natural Product Likeliness | 1.35 |
| NR-PPAR-gamma | 0.98 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.004 |
| HIA | 0.008 |
| CACO-2 | -4.643 |
| MDCK | 0.0000133 |
| BBB | 0.325 |
| PPB | 0.977225 |
| VDSS | 0.536 |
| FU | 0.0200836 |
| CYP1A2-inh | 0.13 |
| CYP1A2-sub | 0.177 |
| CYP2c19-inh | 0.036 |
| CYP2c19-sub | 0.084 |
| CYP2c9-inh | 0.281 |
| CYP2c9-sub | 0.986 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.127 |
| CYP3a4-inh | 0.053 |
| CYP3a4-sub | 0.024 |
| CL | 3.813 |
| T12 | 0.744 |
| hERG | 0.005 |
| Ames | 0.019 |
| ROA | 0.011 |
| SkinSen | 0.955 |
| Carcinogencity | 0.135 |
| EI | 0.985 |
| Respiratory | 0.569 |
| NR-Aromatase | 0.079 |
| Antiviral | Yes |
| Prediction | 0.77575 |